Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBITDA (2020 - 2025)

Clene has reported EBITDA over the past 6 years, most recently at -$9.2 million for Q4 2025.

  • Quarterly results put EBITDA at -$9.2 million for Q4 2025, up 32.82% from a year ago — trailing twelve months through Dec 2025 was -$26.1 million (up 34.04% YoY), and the annual figure for FY2025 was -$26.1 million, up 34.04%.
  • EBITDA for Q4 2025 was -$9.2 million at Clene, down from -$8.8 million in the prior quarter.
  • Over the last five years, EBITDA for CLNN hit a ceiling of $28.9 million in Q3 2021 and a floor of -$39.7 million in Q1 2021.
  • Median EBITDA over the past 5 years was -$8.4 million (2024), compared with a mean of -$7.7 million.
  • Biggest five-year swings in EBITDA: soared 380.36% in 2021 and later plummeted 980.88% in 2023.
  • Clene's EBITDA stood at $4.5 million in 2021, then crashed by 120.9% to -$931000.0 in 2022, then plummeted by 980.88% to -$10.1 million in 2023, then plummeted by 36.15% to -$13.7 million in 2024, then skyrocketed by 32.82% to -$9.2 million in 2025.
  • The last three reported values for EBITDA were -$9.2 million (Q4 2025), -$8.8 million (Q3 2025), and -$7.4 million (Q2 2025) per Business Quant data.